Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BCA101 |
Trade Name | |
Synonyms | BCA-101|BCA 101 |
Drug Descriptions |
BCA101 is a bifunctional antibody that targets both EGFR and TGFB and leads to inhibition of downstream signaling, which may lead to inhibition of tumor cell proliferation and activation of anti-tumor immune response (PMID: 37074042). |
DrugClasses | EGFR Antibody 60 TGFB (Pan) Antibody 5 |
CAS Registry Number | NA |
NCIT ID | C173165 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BCA101 | BCA101 | 1 | 1 |
BCA101 + Pembrolizumab | BCA101 Pembrolizumab | 0 | 1 |
BCA101 + unspecified PD-1 antibody | BCA101 unspecified PD-1 antibody | 0 | 0 |